Edinburgh Research Explorer

Tom Gillingwater comments on new drug to combat children with spinal muscular atrophy

Press/Media: Expert Comment

References

TitleSpinal muscular atrophy drug shows more signs of efficacy
Media name/outletSign On San Diego (USA)
Date of coverage6/12/16
TitleSpinal muscular atrophy drug shows more signs of efficacy
Media name/outletPharmacy Choice (USA)
Date of coverage6/12/16
TitleDrug might help some babies with rare, fatal disease
Media name/outletHealth Day (USA)
Date of coverage6/12/16
TitleDrug might help some babies with rare, fatal disease
Media name/outletU.S. News & World Report (USA)
Date of coverage7/12/16
TitleDrug shows promise for infants with rare, fatal muscle disease
Media name/outletUPI (USA)
Date of coverage7/12/16
TitleRelief for babes with muscle wasting// a new agent can slow the progression of spinal muscular atrophy
Media name/outletDer Tagesspiegel (Germany)
Date of coverage7/12/16
TitleRare disease: relief for babies with muscle wasting
Media name/outletPotsdam Latest News (Germany)
Date of coverage7/12/16
TitleDrug might help some babies with rare, fatal disease
Media name/outletForeignAffairs.co.nz (New Zealand)
Date of coverage7/12/16

ID: 30928394